Health Catalyst, Inc. Quarterly Amortization of Intangible Assets in USD from Q2 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
Health Catalyst, Inc. quarterly/annual Amortization of Intangible Assets history and growth rate from Q2 2018 to Q3 2024.
  • Health Catalyst, Inc. Amortization of Intangible Assets for the quarter ending September 30, 2024 was $6.8M, a 4.23% decline year-over-year.
  • Health Catalyst, Inc. Amortization of Intangible Assets for the twelve months ending September 30, 2024 was $28.8M, a 6.8% decline year-over-year.
  • Health Catalyst, Inc. annual Amortization of Intangible Assets for 2023 was $29.6M, a 20.4% decline from 2022.
  • Health Catalyst, Inc. annual Amortization of Intangible Assets for 2022 was $37.2M, a 16.3% increase from 2021.
  • Health Catalyst, Inc. annual Amortization of Intangible Assets for 2021 was $32M, a 101% increase from 2020.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $28.8M $6.8M -$300K -4.23% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $29.1M $7.5M $0 0% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $29.1M $7.3M -$500K -6.41% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $29.6M $7.2M -$1.3M -15.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-22
Q3 2023 $30.9M $7.1M -$2.3M -24.5% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $33.2M $7.5M -$2.5M -25% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $35.7M $7.8M -$1.5M -16.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 $37.2M $8.5M -$400K -4.49% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-22
Q3 2022 $37.6M $9.4M +$400K +4.44% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 $37.2M $10M +$3M +42.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $34.2M $9.3M +$2.2M +31% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $32M $8.9M +$1.9M +27.1% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-22
Q3 2021 $30.1M $9M +$4.7M +109% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $25.4M $7M +$4.6M +192% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 $20.8M $7.1M +$4.9M +223% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $15.9M $7M +$5.3M +312% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 $10.6M $4.3M +$2.7M +169% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $7.9M $2.4M +$900K +60% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 $7M $2.2M +$700K +46.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 $6.3M $1.7M Oct 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 $1.6M +$200K +14.3% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 $1.5M +$300K +25% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-12
Q1 2019 $1.5M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q3 2018 $1.4M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 $1.2M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.